Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Company Overview - Standard BioTools Inc. is a leading provider of next-generation technologies aimed at assisting biomedical researchers in developing better medicines more efficiently [2] - The company specializes in proprietary mass cytometry and microfluidics technologies, which provide reliable insights into health and disease [2] - Standard BioTools collaborates with various sectors including academic, government, pharmaceutical, biotechnology, and clinical laboratories globally, focusing on translational and clinical research needs [2] Financial Announcement - Standard BioTools Inc. will release its fourth quarter and full year 2025 financial results on February 24, 2026, after the U.S. market closes [1]